Clinical Trial Update: Neoadjuvant Toripalimab in Combination with Gemcitabine and Cisplatin Therapy in Local Advanced Bladder Cancer Subjects [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant trial evaluating toripalimab in combination with gemcitabine and cisplatin for locally advanced bladder cancer; currently recruiting at Zhuj…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Zhujiang Hospital | Conditions: Urinary Bladder Cancer | Phase 2 | Status: RECRUITING